{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:37:20Z","timestamp":1788453440860,"version":"build-2803163510"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171028","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T18:28:23Z","timestamp":1488392903000},"page":"e0171028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-8801","authenticated-orcid":false,"given":"Nigar","family":"Sekercioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argie","family":"Angeliki Veroniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason W.","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noori","family":"Akhtar-Danesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane","family":"Cruz Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"AS Levey","year":"2003","journal-title":"Annals of internal medicine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","article-title":"Vascular calcification and renal osteodystrophy relationship in chronic kidney disease","volume":"36","author":"SM Moe","year":"2006","journal-title":"European Journal of Clinical Investigation"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-9343(79)91118-5","article-title":"Arterial calcification and pathology in uremic patients undergoing dialysis","volume":"66","author":"LS Ibels","year":"1979","journal-title":"Am J Med"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"AK Cheung","year":"2000","journal-title":"Kidney Int"},{"issue":"2","key":"ref5","first-page":"157","article-title":"Valvular calcifications at the start of dialysis predict the onset of cardiovascular events in the course of follow-up","volume":"35","author":"C Sanchez-Perales","year":"2015","journal-title":"Nefrologia"},{"key":"ref6","first-page":"1","article-title":"Valvular calcification and left ventricular modifying in peritoneal dialysis patients","author":"D Rebic","year":"2015","journal-title":"Ren Fail"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40697-015-0065-6","article-title":"Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis","volume":"2","author":"TJ Wilkieson","year":"2015","journal-title":"Can J Kidney Health Dis"},{"issue":"4 Suppl 3","key":"ref8","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"ref9","article-title":"Hyperphosphataemia in Chronic Kidney Disease: Management of Hyperphosphataemia in Patients with Stage 4 or 5 Chronic Kidney Disease","year":"2013"},{"key":"ref10","unstructured":"Hyperphosphataemia in chronic kidney disease Evidence Update December 2014. NICE guidelines [Internet]. 2014."},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"GA Block","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"S Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","article-title":"Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease","volume":"26","author":"CM O'Seaghdha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"N Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"ref15","first-page":"33","article-title":"New agent to treat elevated phosphate levels: magnesium carbonate\/calcium carbonate tablets","volume":"22","author":"C Meyer","year":"2012","journal-title":"CANNT journal = Journal ACITN"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S78040","article-title":"Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide","volume":"9","author":"V Cernaro","year":"2016","journal-title":"International journal of nephrology and renovascular disease"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14740338.2014.907791","article-title":"Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles","volume":"13","author":"F Locatelli","year":"2014","journal-title":"Expert opinion on drug safety"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/1389200216666150206124424","article-title":"Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide","volume":"15","author":"M Cozzolino","year":"2014","journal-title":"Current drug metabolism"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40620-014-0108-6","article-title":"Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"CT Lee","year":"2015","journal-title":"J Nephrol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11255-014-0876-x","article-title":"Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"47","author":"CJ Zhai","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"9900","key":"ref21","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"SA Jamal","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"e0156891","DOI":"10.1371\/journal.pone.0156891","article-title":"Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis","volume":"11","author":"N Sekercioglu","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/j.ajkd.2015.03.036","article-title":"Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis","volume":"66","author":"SC Palmer","year":"2015","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"GA Block","year":"1998","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"113","key":"ref25","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney international Supplement"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder","volume":"17","author":"M Fukagawa","year":"2013","journal-title":"Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"},{"issue":"3 Suppl 1","key":"ref27","first-page":"S1","article-title":"Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology","volume":"17","author":"K Jindal","year":"2006","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","article-title":"Guidelines for the management of chronic kidney disease","volume":"179","author":"A Levin","year":"2008","journal-title":"CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"B Hutton","year":"2015","journal-title":"Annals of internal medicine"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"JP Higgins","year":"2009","journal-title":"Journal of the Royal Statistical Society Series A, (Statistics in Society)"},{"issue":"7650","key":"ref31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ (Clinical research ed)"},{"issue":"7454","key":"ref32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"D Atkins","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"GH Guyatt","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","year":"2014","journal-title":"BMJ"},{"issue":"16","key":"ref35","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"T Lumley","year":"2002","journal-title":"Statistics in medicine"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"IR White","year":"2012","journal-title":"Research synthesis methods"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"JP Higgins","year":"2012","journal-title":"Research synthesis methods"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"A Chaimani","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"A Chaimani","year":"2013","journal-title":"PloS one"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/sim.1189","article-title":"Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales","volume":"21","author":"DE Warn","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"Journal of clinical epidemiology"},{"key":"ref42","article-title":"The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes","author":"AA Veroniki","year":"2016","journal-title":"Journal of clinical epidemiology"},{"key":"ref43","unstructured":"Gert van Valkenhoef, Kuiper J. gemtc: Network Meta-Analysis Using Bayesian Methods. R package version 0.8. gemtc: Network Meta-Analysis Using Bayesian Methods R package version 08 [Internet]. 2016."},{"key":"ref44","article-title":"R: A language and environment for statistical computing","year":"2015"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study","volume":"110","author":"DV Barreto","year":"2008","journal-title":"Nephron Clinical practice"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2014.10.014","article-title":"A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3\u20135","volume":"65","author":"GA Block","year":"2015","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"GA Block","year":"2007","journal-title":"Kidney international"},{"issue":"8","key":"ref48","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"GA Block","year":"2012","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"GM Chertow","year":"2002","journal-title":"Kidney international"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/ndt\/gfq292","article-title":"Evaluation of calcium acetate\/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability","volume":"25","author":"AL de Francisco","year":"2010","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"B Di Iorio","year":"2012","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"B Di Iorio","year":"2013","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.2014.58","article-title":"A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients","volume":"86","author":"J Floege","year":"2014","journal-title":"Kidney international"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","article-title":"Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients","volume":"57","author":"T Kakuta","year":"2011","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40620-014-0108-6","article-title":"Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"CT Lee","year":"2015","journal-title":"Journal of nephrology"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5414\/CN107362","article-title":"Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study","volume":"79","author":"YK Lee","year":"2013","journal-title":"Clinical nephrology"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1681\/ASN.2014020212","article-title":"Ferric citrate controls phosphorus and delivers iron in patients on dialysis","volume":"26","author":"JB Lewis","year":"2015","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1074248413486355","article-title":"Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study","volume":"18","author":"T Ohtake","year":"2013","journal-title":"Journal of cardiovascular pharmacology and therapeutics"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"W Qunibi","year":"2008","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"D Russo","year":"2007","journal-title":"Kidney international"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ndt\/18.3.582","article-title":"Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study","volume":"18","author":"T Sadek","year":"2003","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.jrn.2007.10.019","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial","volume":"18","author":"WN Suki","year":"2008","journal-title":"Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5414\/CN108269","article-title":"Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a randomized trial","volume":"82","author":"Y Takahara","year":"2014","journal-title":"Clinical nephrology"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"c278","DOI":"10.1159\/000127361","article-title":"Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis","volume":"108","author":"T Takei","year":"2008","journal-title":"Nephron Clinical practice"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1797.2010.01412.x","article-title":"Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial","volume":"16","author":"ND Toussaint","year":"2011","journal-title":"Nephrology (Carlton, Vic)"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2369-15-71","article-title":"Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial","volume":"15","author":"P Urena-Torres","year":"2014","journal-title":"BMC nephrology"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1744-9987.12153","article-title":"Evaluation of aortic calcification with lanthanum carbonate vs. calcium-based phosphate binders in maintenance hemodialysis patients with type 2 diabetes mellitus: an open-label randomized controlled trial","volume":"18","author":"K Wada","year":"2014","journal-title":"Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy"},{"issue":"12","key":"ref68","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1185\/03007990903399398","article-title":"Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy","volume":"25","author":"R Wilson","year":"2009","journal-title":"Current medical research and opinion"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.08230811","article-title":"Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients","volume":"8","author":"RP Wuthrich","year":"2013","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2369-14-29","article-title":"Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China","volume":"14","author":"J Xu","year":"2013","journal-title":"BMC nephrology"},{"issue":"5","key":"ref71","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/ndt\/gft483","article-title":"A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis","volume":"29","author":"K Yokoyama","year":"2014","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.05170513","article-title":"Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD","volume":"9","author":"K Yokoyama","year":"2014","journal-title":"Clinical journal of the American Society of Nephrology: CJASN"},{"issue":"4","key":"ref73","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11255-009-9688-9","article-title":"Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3\u20134","volume":"42","author":"A Gulati","year":"2010","journal-title":"International urology and nephrology"},{"issue":"1","key":"ref74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"GM Chertow","year":"1997","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"ref75","article-title":"Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis","author":"N S","year":"2016","journal-title":"PLOS ONE"},{"issue":"10","key":"ref76","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/0886022X.2015.1087862","article-title":"Associations among time-average mineral values, mortality and cardiovascular events in hemodialysis patients","volume":"37","author":"HC Wu","year":"2015","journal-title":"Renal failure"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"515606","DOI":"10.1155\/2015\/515606","article-title":"Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure","volume":"2015","author":"O Phan","year":"2015","journal-title":"BioMed research international"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000440968","article-title":"Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency","volume":"131","author":"A Iguchi","year":"2015","journal-title":"Nephron"},{"issue":"5","key":"ref79","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/089686089901900509","article-title":"Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients","volume":"19","author":"JF Navarro","year":"1999","journal-title":"Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3904\/kjim.2002.17.2.114","article-title":"Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate","volume":"17","author":"MS Cho","year":"2002","journal-title":"The Korean journal of internal medicine"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11255-006-0082-6","article-title":"Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?","volume":"38","author":"M Wei","year":"2006","journal-title":"International urology and nephrology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T07:38:34Z","timestamp":1601710714000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171028"}},"subtitle":[],"editor":[{"given":"Gianpaolo","family":"Reboldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":81,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171028","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}